POINT Biopharma Global Inc. focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioliand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the. treatment of non-metastatic. castration sensitive prostate cancer, which is under study.
Market Cap | 1.46 Billion | Shares Outstanding | 105.766 Million | Avg 30-day Volume | 2.869 Million |
P/E Ratio | 9.8431 | Dividend Yield | 0.0 | EPS | -0.23 |
Price to Revenue | 3.9761 | Debt to Equity | 0.0339 | EBITDA | 106.004 Million |
Price to Book Value | 2.1407 | Operating Margin | 0.0 | Enterprise Value | 915.725 Million |
Current Ratio | EPS Growth | 2.305 | Quick Ratio | ||
1 Yr BETA | 0.084 | 52-week High/Low | 13.9 / 6.39 | Profit Margin | 40.395 |
Operating Cash Flow Growth | 309.2573 | Free Cash Flow to Firm (FCFF) TTM | -152.875 Million | Free Cash Flow to Equity (FCFE) TTM | 65.876 Million |
Altman Z-Score |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
MCCANN JOE A. CHIEF EXECUTIVE OFFICER |
|
3,496,313 | 2023-11-06 | 2 |
SILBER ALLAN C EXECUTIVE CHAIRMAN |
|
8,727,975 | 2023-11-03 | 2 |
BIOTECHNOLOGY VALUE FUND II LP |
|
17,161,278 | 2023-11-02 | 1 |
FLESHNER NEIL E. CHIEF MEDICAL OFFICER |
|
3,006,574 | 2023-10-31 | 2 |
|
0 | 2023-06-13 | 2 | |
|
0 | 2023-06-01 | 1 | |
|
0 | 2023-06-01 | 1 | |
|
0 | 2023-06-01 | 1 | |
|
0 | 2023-06-01 | 1 | |
|
0 | 2023-06-01 | 2 | |
DEMERS WILLIAM L. CHIEF FINANCIAL OFFICER |
|
0 | 2023-03-28 | 1 |
JENSEN JESSICA D. EVP CLINICAL DEVELOPMENT |
|
0 | 2023-03-28 | 1 |
KELLY JUSTYNA CHIEF OPERATING OFFICER |
|
0 | 2023-03-28 | 1 |
GOTTLIEB MICHAEL M. CHIEF COMMERCIAL OFFICER |
|
48,000 | 2021-07-06 | 0 |
|
25,000 | 2021-07-06 | 0 | |
|
1,098,318 | 2021-06-29 | 0 | |
KOLCHINSKY PETER CHIEF EXECUTIVE OFFICER |
|
1,098,318 | 2021-06-29 | 0 |
|
0 | 2020-07-07 | 0 | |
|
0 | 2020-07-07 | 0 | |
|
0 | 2020-07-07 | 0 | |
HAMMOND MATTHEW CHIEF FINANCIAL OFFICER |
|
0 | 2020-07-07 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCCANN JOE A. - Director - Officer CHIEF EXECUTIVE OFFICER personal holding company |
2023-11-07 18:33:24 -0500 | 2023-11-06 | G | 120,000 | d | 3,494,153 | indirect | 1.3825 | 2.9186 | 2.9186 | 6 | 0.0 | 1 | |||
SILBER ALLAN C - Director - Officer EXECUTIVE CHAIRMAN trustee |
2023-11-07 18:31:49 -0500 | 2023-11-03 | G | 500,000 | d | 38,087 | indirect | 1.3825 | 2.9186 | 2.9186 | 6 | 0.0 | 1 | |||
2023-11-02 18:30:24 -0400 | 2023-10-31 | G | 250,000 | d | 2,773,045 | direct | 2.2745 | 2.902 | 3.5294 | 5 | 0.0 | 1 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 22:15:04 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 21:45:03 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 21:15:04 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 20:45:04 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 20:15:04 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 19:45:03 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 19:15:04 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 18:45:03 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 18:15:03 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 17:45:04 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 17:15:04 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 16:45:04 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 16:15:04 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 15:45:03 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 15:15:03 UTC | 4.7052 | 0.6148 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 14:45:04 UTC | 4.7045 | 0.6155 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 14:15:04 UTC | 4.7045 | 0.6155 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 13:45:04 UTC | 4.7045 | 0.6155 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 13:15:03 UTC | 4.7045 | 0.6155 | 1900000 |
POINT BIOPHARMA GLOBAL INC PNT | 2023-11-28 12:45:04 UTC | 4.7045 | 0.6155 | 1900000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|